A review of the neurobiology of obesity and the available pharmacotherapies

CNS Spectr. 2017 Dec;22(S1):29-38. doi: 10.1017/S1092852917000839.

Abstract

Obesity is becoming an increasing problem worldwide. In addition to causing many physical health consequences, there is increasing evidence demonstrating that obesity is toxic to the brain and, as such, can be considered a disease of the central nervous system. Peripheral level regulators of appetite, such as leptin, insulin, ghrelin, and cholecystokinin, feed into the appetite center of the brain, which is controlled by the hypothalamus, to maintain homeostasis and energy balance. However, food consumption is not solely mediated by energy balance, but is also regulated by the mesolimbic reward system, where motivation, reward, and reinforcement factors influence obesity. The purpose of this review is to highlight the neurobiology of eating behavior and obesity and to describe various neurobiological treatment mechanisms to treat obesity.

Keywords: Brain toxicity; energy balance; hypothalamus; mesolimbic reward system; weight-loss treatment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-Obesity Agents / therapeutic use*
  • Brain / metabolism
  • Brain / physiopathology*
  • Energy Metabolism / physiology
  • Humans
  • Obesity / drug therapy*
  • Obesity / metabolism
  • Obesity / physiopathology*

Substances

  • Anti-Obesity Agents